Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitorsHidetoshi Sumimoto, Yataro Daigo, Kosuke Sakai et al.|PLoS ONE|2024Cited by 16
Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer PatientsHidetoshi Sumimoto, Yataro Daigo, Komaki Hayashi et al.|Palliative Medicine Reports|2021Cited by 8
<sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Tumor Immune Microenvironment Function in Early Triple-negative Breast CancerYuri Kimura, Morihito Okada|Anticancer Research|2022Cited by 8